Back to search results

Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)

Abroad (travel likely)RecruitingPHASE2

Conditions

Chronic Pruritus of Unknown Origin

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Galderma Investigational Site (site# 8893), Birmingham, Alabama, United States

  • Galderma Investigational Site (#8768), Tucson, Arizona, United States

  • Galderma Investigational Site (site# 8636), Fountain Valley, California, United States

  • Galderma Investigational Site (site# 8130), Los Angeles, California, United States

  • Galderma Investigational Site (#9975), Sacramento, California, United States

  • Galderma Investigational Site (site# 8021), San Diego, California, United States

  • Galderma Investigational Site (site# 7075), San Francisco, California, United States

  • Galderma Investigational Site (site# 8608), Santa Monica, California, United States

  • Galderma Investigational Site (#8295), Miami, Florida, United States

  • Galderma Investigational Site (site# 7054), Tampa, Florida, United States

  • Galderma Investigational Site (site# 8142), Indianapolis, Indiana, United States

  • Galderma Investigational Site (#7129), Bowling Green, Kentucky, United States

  • Galderma Investigational (Site# 7048), Baltimore, Maryland, United States

  • Galderma Investigational Site (site# 8743), Ann Arbor, Michigan, United States

  • Galderma Investigational Site (site# 8521), Saint Joseph, Missouri, United States

  • Galderma Investigational Site (site# 8108), Las Vegas, Nevada, United States

  • Galderma Investigational Site (site# 7110), New City, New York, United States

  • Galderma Investigational Site (#7130), The Bronx, New York, United States

  • Galderma Investigational Site (site# 7111), Fargo, North Dakota, United States

  • Galderma Investigational Site (#8212), Portland, Oregon, United States

  • Galderma Investigational Site (#8255), Philadelphia, Pennsylvania, United States

  • Galderma Investigational (Site # 7131), Spartanburg, South Carolina, United States

  • Galderma Investigational Site (site# 8003), Webster, Texas, United States

  • Galderma Investigational Site (site# 8862), Fairfax, Virginia, United States

  • Galderma Investigational Site (site# 8725), Morgantown, West Virginia, United States

  • Galderma Investigational Site (site# 8045), Québec, Quebec, Canada

View source on ClinicalTrials.gov(opens in a new tab)